We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

If Less Is More, Which Outcomes Should Be Presented in Facilitating Prostate Cancer Screening Decision Making?

Melissa R. Partin, PhD1; Adam A. Powell, PhD1
[+] Author Affiliations
1Minneapolis Veterans Affairs Health Care System, Center for Chronic Disease Outcomes Research, Minneapolis, Minnesota
JAMA Intern Med. 2013;173(17):1656-1657. doi:10.1001/jamainternmed.2013.8155.
Text Size: A A A
Published online


To the Editor The study by Pignone and colleagues,1 which found that the relative importance patients assign to specific prostate cancer screening outcomes depends on the method used to summarize them, provides sobering documentation of how sensitive patient opinions can be to differences in presentation. Given previous research documenting that less can be more in communicating complex risk information to patients,2 the authors appropriately limit the number of outcomes presented in their values clarification exercises to 4. However, it is not clear why they selected these particular outcomes over other potentially relevant outcomes. We recognize that the focus of the study by Pignone et al1 was not to identify which outcomes to highlight in a decision aid, but rather to evaluate whether the type of values clarification exercise used affects the judgments derived from this process. However, the selection of outcomes highlighted may have had a large effect on the overall preference for screening observed and may very well be the most critical issue to address in applying the findings from their study to the design of future decision aids. If presenting all the potential outcomes would be overwhelming for patients, we believe that the most critical outcomes to present are those relating directly to morbidity and mortality. In the study by Pignone et al,1 2 of the outcomes included in the values clarification exercises meet this criteria (the chance of developing impotence and incontinence as a result of screening and the chance of dying of prostate cancer). The remaining 2 outcomes do not (the chance of being diagnosed as having prostate cancer and the chance of requiring a prostate biopsy). For these outcomes, patients must infer the morbidity and mortality implications of each state. In a recent review of the literature, the US Preventive Services Task Force estimated that the number of men who will avoid a prostate cancer death through screening is between 0 and 1 per 1000 men screened.3 However, they found no evidence of an all-cause mortality benefit and estimated that 5 men in 1000 would experience a life-threatening complication (ie, blood clot, myocardial infarction, infection-related hospitalization) from follow-up procedures. If less is more, we believe future decision aids should find ways to incorporate information on these serious complications. Although less prevalent than some of the more commonly highlighted harms of prostate cancer screening (eg, false-positive biopsy results, treatment-related impotence and incontinence), they are more serious and more likely to occur than a survival benefit from screening.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





September 23, 2013
Michael P. Pignone, MD, MPH
1Cecil G. Sheps Center for Health Services Research and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill2Department of Medicine, University of North Carolina at Chapel Hill
JAMA Intern Med. 2013;173(17):1657. doi:10.1001/jamainternmed.2013.8132.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Related Collections